Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension

Published:2002-06 Issue:6 Volume:121 Page:1860-1868
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Barst Robyn J.,Rich Stuart,Widlitz Allison,Horn Evelyn M.,McLaughlin Vallerie,McFarlin Joyce

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference30 articles.

1. Primary pulmonary hypertension;Rubin;N Engl J Med,1997

2. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension;Rich;N Engl J Med,1992

3. Vasodilator therapy for primary pulmonary hypertension in children;Barst;Circulation,1999

4. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin);Higenbottam;Lancet,1984

5. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial;Rubin;Ann Intern Med,1990

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying the Interaction Between Tuberculosis and SARS-CoV-2 Infections via Bioinformatics Analysis and Machine Learning;Biochemical Genetics;2023-11-22

2. Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease;Diabetes, Obesity and Metabolism;2023-05-04

3. No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials;International Journal of Molecular Sciences;2023-01-05

4. Recent Advances in the Treatment of Pulmonary Arterial Hypertension;Pharmaceuticals;2022-10-17

5. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies;American Journal of Physiology-Heart and Circulatory Physiology;2022-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3